Self-monitoring of blood glucose in type 2 diabetes: steps toward consensus
Those involved in type 2 diabetes care must be puzzled by the lack of consensus on self-monitoring of blood glucose (SMBG) (1,2,3), especially in non–insulin-treated patients. This is reflected by wide between-country variation in reimbursement for glucose meters and strips. Balanced evaluation of a...
| Autores: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versão publicada |
| Data de publicação: | 2008 |
| País: | Argentina |
| Recursos: | Consejo Nacional de Investigaciones Científicas y Técnicas |
| Repositório: | CONICET Digital (CONICET) |
| Idioma: | inglês |
| OAI Identifier: | oai:ri.conicet.gov.ar:11336/137402 |
| Acesso em linha: | http://hdl.handle.net/11336/137402 |
| Access Level: | Acceso aberto |
| Palavra-chave: | NON-INSULIN TREATED SELF-MONITORING OF BLOOD GLUCOSE TYPE 2 DIABETES https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| Resumo: | Those involved in type 2 diabetes care must be puzzled by the lack of consensus on self-monitoring of blood glucose (SMBG) (1,2,3), especially in non–insulin-treated patients. This is reflected by wide between-country variation in reimbursement for glucose meters and strips. Balanced evaluation of available data is required; however, further trials are needed to provide robust evidence as to how and in which groups SMBG use is justified. |
|---|